Search research articles
Contact Us
Filters
Showing results (1031-1040 of 1,153) with videos related to
Page
of 116
Sort By:
International Journal of Molecular Sciences
|
January 8, 2025
Whole-Exome Sequencing, Mutational Signature Analysis, and Outcome in Multiple Myeloma-A Pilot Study
Lorenz Oelschläger, Axel Künstner, Friederike Frey, et al.
Blood
|
August 26, 2010
Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL
German Ott, Marita Ziepert, Wolfram Klapper, et al.
Leukemia
|
August 22, 2017
Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing
A Zamò, J Pischimarov, M Schlesner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 24, 2008
Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens
Mark E Dudley, James C Yang, Richard Sherry, et al.
Blood Advances
|
October 28, 2022
Baseline radiomics features and MYC rearrangement status predict progression in aggressive B-cell lymphoma
Jakoba J Eertink, Gerben J C Zwezerijnen, Sanne E Wiegers, et al.
Leukemia
|
September 19, 2019
A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL
Annette M Staiger, Michael Altenbuchinger, Marita Ziepert, et al.
Blood Advances
|
May 24, 2022
A unifying hypothesis for PNMZL and PTFL: morphological variants with a common molecular profile
Julia Salmeron-Villalobos, Caoimhe Egan, Vanessa Borgmann, et al.
Leukemia
|
December 2, 2015
Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locus
E Leich, E Hoster, M Wartenberg, et al.
Leukemia
|
February 18, 2015
Different biological risk factors in young poor-prognosis and elderly patients with diffuse large B-cell lymphoma
H Horn, M Ziepert, M Wartenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 5, 2022
High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma: Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma Network
Olivier Hermine, Linmiao Jiang, Jan Walewski, et al.
Page
of 116
Search research articles
Search
Showing results (1031-1040 of 1,153) with videos related to
Sort By:
Page
of 116
International Journal of Molecular Sciences
|
January 8, 2025
Whole-Exome Sequencing, Mutational Signature Analysis, and Outcome in Multiple Myeloma-A Pilot Study
Lorenz Oelschläger, Axel Künstner, Friederike Frey, et al.
Blood
|
August 26, 2010
Immunoblastic morphology but not the immunohistochemical GCB/nonGCB classifier predicts outcome in diffuse large B-cell lymphoma in the RICOVER-60 trial of the DSHNHL
German Ott, Marita Ziepert, Wolfram Klapper, et al.
Leukemia
|
August 22, 2017
Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole-exome sequencing
A Zamò, J Pischimarov, M Schlesner, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 24, 2008
Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens
Mark E Dudley, James C Yang, Richard Sherry, et al.
Blood Advances
|
October 28, 2022
Baseline radiomics features and MYC rearrangement status predict progression in aggressive B-cell lymphoma
Jakoba J Eertink, Gerben J C Zwezerijnen, Sanne E Wiegers, et al.
Leukemia
|
September 19, 2019
A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL
Annette M Staiger, Michael Altenbuchinger, Marita Ziepert, et al.
Blood Advances
|
May 24, 2022
A unifying hypothesis for PNMZL and PTFL: morphological variants with a common molecular profile
Julia Salmeron-Villalobos, Caoimhe Egan, Vanessa Borgmann, et al.
Leukemia
|
December 2, 2015
Similar clinical features in follicular lymphomas with and without breaks in the BCL2 locus
E Leich, E Hoster, M Wartenberg, et al.
Leukemia
|
February 18, 2015
Different biological risk factors in young poor-prognosis and elderly patients with diffuse large B-cell lymphoma
H Horn, M Ziepert, M Wartenberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 5, 2022
High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma: Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma Network
Olivier Hermine, Linmiao Jiang, Jan Walewski, et al.
Page
of 116